Education
About Us
Working with TipRanks
Follow Us
Avantor Inc (AVTR)
NYSE:AVTR
Earnings Data
Report Date
Jul 24, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
0.25Last Year’s EPS
0.25Same Quarter Last Year
Moderate Buy
Based on 16 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Apr 25, 2025
|% Change Since: -13.48%
|Next Earnings Date:Jul 24, 2025
Earnings Call Sentiment|Neutral
The earnings call reflected a challenging quarter with a significant focus on addressing underperformance and external headwinds. While there were positive developments in cost savings and product expansion, the overall sentiment was affected by revenue declines, CEO transition, and market pressures.Company Guidance
In the first quarter of fiscal year 2025, Avantor experienced a 2% year-over-year decline in organic revenue, driven primarily by a 3% decline in the Lab Solutions segment and flat performance in the Bioscience Production segment. Despite this, the company managed an adjusted EBITDA margin increase of 20 basis points to 17%, supported by its ongoing multiyear cost transformation initiative, which aims to achieve $400 million in run-rate gross savings by the end of 2027. Adjusted earnings per share (EPS) for the quarter were $0.23, aligning with expectations. Due to macroeconomic headwinds, including a 40% funding drop for bench-stage biotech companies and caution in the education and government markets, Avantor revised its full-year guidance to reflect organic revenue growth between -1% to 1%, with adjusted EBITDA margin projected at 17.5% to 18.5%. The company is focusing on enhancing growth, expanding margins, and reducing leverage through strategic initiatives such as supply chain optimization, digital platform enhancements, and strategic pricing adjustments.Cost Transformation Initiative Expansion
Avantor announced the expansion of its cost transformation initiative, aiming to achieve $400 million in run rate savings by the end of 2027, up from the previous target of $300 million by 2026.
Order Book Strength in Bioprocessing
Avantor reported strong order intake in its Bioprocessing segment, with continued momentum and recovery, indicating robust end market fundamentals.
New Product and Distribution Agreements
The company signed new agreements with Abcam and Fuji Film Bovine Scientific to expand its product portfolio, adding thousands of SKUs to its Lab Solutions and Bioscience Production segments.
Adjusted EBITDA Margin Improvement
Adjusted EBITDA margin increased by 20 basis points year-over-year to 17%, driven by the multiyear cost transformation initiatives.
---
AVTR Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
AVTR Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Apr 25, 2025 | $15.50 | $12.93 | -16.58% |
Feb 07, 2025 | $21.70 | $19.16 | -11.71% |
Oct 25, 2024 | $23.27 | $22.43 | -3.61% |
Jul 26, 2024 | $22.82 | $25.60 | +12.18% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Avantor Inc (AVTR) report earnings?
Avantor Inc (AVTR) is schdueled to report earning on Jul 24, 2025, TBA Not Confirmed.
What is Avantor Inc (AVTR) earnings time?
Avantor Inc (AVTR) earnings time is at Jul 24, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is AVTR EPS forecast?
AVTR EPS forecast for the fiscal quarter 2025 (Q2) is 0.25.
---